title: [Impulsivity in adolescents with attention deficit hyperactivity disorder].
abstract: OBJECTIVE
  To study impulsivity in adolescents with attention deficit hyperactivity disorder (ADHD) and evaluate the efficacy of noophen in dosage 500 mg daily for 45 days in the treatment of this disorder.
  
  
  METHODS
  The results of the clinical, psychological and psycho-physiological study of 60 adolescents with ADHD, aged 12 to 15 years, have been analyzed. A comparative analysis of the clinical picture of the disease and the data of psychophysiological examination of ADHD predominantly hyperactive (ADHD-H) and the combined type of the disease are presented as well. The study shows significantly higher levels of anxiety and impulsivity in children with ADHD-H. The efficacy of noophen in the treatment of this group of patients has been evaluated.
  
  
  CONCLUSIONS
  The high clinical efficacy of noophen is shown. After treatment, the improvement has been obtained in 63.3% of patients.
authors.affiliation: N. Bekhtereva Human Brain Research Institute, Russian Academy of Sciences, St. Petersburg, Russia.
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.affiliation: N. Bekhtereva Human Brain Research Institute, Russian Academy of Sciences, St. Petersburg, Russia.
authors.forename: E Yu
authors.initials: EY
authors.lastname: Surushkina
authors.affiliation: N. Bekhtereva Human Brain Research Institute, Russian Academy of Sciences, St. Petersburg, Russia.
authors.forename: E A
authors.initials: EA
authors.lastname: Yakovenko
authors.affiliation: N. Bekhtereva Human Brain Research Institute, Russian Academy of Sciences, St. Petersburg, Russia.
authors.forename: Yu D
authors.initials: YD
authors.lastname: Kropotov
authors.affiliation: N. Bekhtereva Human Brain Research Institute, Russian Academy of Sciences, St. Petersburg, Russia.
authors.forename: T I
authors.initials: TI
authors.lastname: Anisimova
authors.affiliation: N. Bekhtereva Human Brain Research Institute, Russian Academy of Sciences, St. Petersburg, Russia.
authors.forename: A V
authors.initials: AV
authors.lastname: Sergeev
mesh_terms: D000293:Adolescent; D001007:Anxiety; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology*; D002648:Child; D018755:GABA Agonists / Q000627:therapeutic use*; D006801:Humans; D007175:Impulsive Behavior; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D018755:GABA Agonists; D005680:gamma-Aminobutyric Acid; C008842:4-amino-3-phenylbutyric acid